secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001193125-25-276249
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell Therapeutics sells 12M shares at $1.75 to Janus Henderson, grossing $21M
--------------------------------------------------------------------------------

- Sold 12,000,000 common shares at $1.75 per share to Janus Henderson Investors in a block transaction.
- Gross proceeds of $21 million before fees and expenses; net proceeds not disclosed.
- Transaction executed under the company's existing at-the-market offering program.
- Shares trade on NYSE American under ticker LCTX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000119312525276249/0001193125-25-276249-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000119312525276249/lctx-20251112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-276249

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer